At the World Vaccine Congress 2023 held in Washington, USA from April 3-6, Bharat Biotech was awarded the Best Production/Process Development award as a part of the Vaccine Industry Excellence (ViE) awards.
Hyderabad-based Bharat Biotech was the only Indian company in the list of VIE awards in various categories, including best clinical trial company, best clinical trial network, best central/specialty laboratory award, best contract research organisation, best production/process development award, among others.
Bharat Biotech, a pioneering biotechnology company, has developed the world's first intranasal COVID-19 vaccine called iNcovacc.
The World Vaccine Congress is the largest global meeting dedicated to vaccines. From basic research to commercial manufacture, it covers the whole vaccine value chain.
Apart from uniting vaccine experts, it was instrumental in sharing groundbreaking knowledge in tackling the pandemic.
